1. Home
  2. BNTC vs ESEA Comparison

BNTC vs ESEA Comparison

Compare BNTC & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • ESEA
  • Stock Information
  • Founded
  • BNTC 1995
  • ESEA 2005
  • Country
  • BNTC United States
  • ESEA Greece
  • Employees
  • BNTC N/A
  • ESEA N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • ESEA Marine Transportation
  • Sector
  • BNTC Health Care
  • ESEA Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • ESEA Nasdaq
  • Market Cap
  • BNTC 365.1M
  • ESEA 428.7M
  • IPO Year
  • BNTC N/A
  • ESEA 2006
  • Fundamental
  • Price
  • BNTC $13.06
  • ESEA $59.75
  • Analyst Decision
  • BNTC Strong Buy
  • ESEA Strong Buy
  • Analyst Count
  • BNTC 5
  • ESEA 1
  • Target Price
  • BNTC $26.60
  • ESEA $62.00
  • AVG Volume (30 Days)
  • BNTC 304.0K
  • ESEA 35.9K
  • Earning Date
  • BNTC 11-14-2025
  • ESEA 11-18-2025
  • Dividend Yield
  • BNTC N/A
  • ESEA 4.72%
  • EPS Growth
  • BNTC N/A
  • ESEA 6.77
  • EPS
  • BNTC N/A
  • ESEA 17.38
  • Revenue
  • BNTC N/A
  • ESEA $223,794,428.00
  • Revenue This Year
  • BNTC N/A
  • ESEA $10.39
  • Revenue Next Year
  • BNTC N/A
  • ESEA $0.01
  • P/E Ratio
  • BNTC N/A
  • ESEA $3.21
  • Revenue Growth
  • BNTC N/A
  • ESEA 7.26
  • 52 Week Low
  • BNTC $9.10
  • ESEA $26.30
  • 52 Week High
  • BNTC $17.15
  • ESEA $66.00
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 39.49
  • ESEA 52.02
  • Support Level
  • BNTC $12.47
  • ESEA $53.44
  • Resistance Level
  • BNTC $13.94
  • ESEA $61.82
  • Average True Range (ATR)
  • BNTC 1.27
  • ESEA 2.99
  • MACD
  • BNTC -0.18
  • ESEA 0.09
  • Stochastic Oscillator
  • BNTC 29.06
  • ESEA 68.62

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

Share on Social Networks: